Quality-of-life impairment in depressive and anxiety disorders
- PMID: 15930066
- DOI: 10.1176/appi.ajp.162.6.1171
Quality-of-life impairment in depressive and anxiety disorders
Abstract
Objective: Previous reports demonstrating quality-of-life impairment in anxiety and affective disorders have relied upon epidemiological samples or relatively small clinical studies. Administration of the same quality-of-life scale, the Quality of Life Enjoyment and Satisfaction Questionnaire, to subjects entering multiple large-scale trials for depression and anxiety disorders allowed us to compare the impact of these disorders on quality of life.
Method: Baseline Quality of Life Enjoyment and Satisfaction Questionnaire, demographic, and clinical data from 11 treatment trials, including studies of major depressive disorder, chronic/double depression, dysthymic disorder, panic disorder, obsessive-compulsive disorder (OCD), social phobia, premenstrual dysphoric disorder, and posttraumatic stress disorder (PTSD) were analyzed.
Results: The proportion of patients with clinically severe impairment (two or more standard deviations below the community norm) in quality of life varied with different diagnoses: major depressive disorder (63%), chronic/double depression (85%), dysthymic disorder (56%), panic disorder (20%), OCD (26%), social phobia (21%), premenstrual dysphoric disorder (31%), and PTSD (59%). Regression analyses conducted for each disorder suggested that illness-specific symptom scales were significantly associated with baseline quality of life but explained only a small to modest proportion of the variance in Quality of Life Enjoyment and Satisfaction Questionnaire scores.
Conclusions: Subjects with affective or anxiety disorders who enter clinical trials have significant quality-of-life impairment, although the degree of dysfunction varies. Diagnostic-specific symptom measures explained only a small proportion of the variance in quality of life, suggesting that an individual's perception of quality of life is an additional factor that should be part of a complete assessment.
Similar articles
-
Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.Compr Psychiatry. 2003 Sep-Oct;44(5):360-9. doi: 10.1016/S0010-440X(03)00111-1. Compr Psychiatry. 2003. PMID: 14505296 Clinical Trial.
-
Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder.Int Clin Psychopharmacol. 2008 Sep;23(5):276-86. doi: 10.1097/YIC.0b013e328303ac5f. Int Clin Psychopharmacol. 2008. PMID: 18703937 Clinical Trial.
-
Spotlight on paroxetine in psychiatric disorders in adults.CNS Drugs. 2002;16(6):425-34. doi: 10.2165/00023210-200216060-00006. CNS Drugs. 2002. PMID: 12027788 Review.
-
Quality of life impairment in generalized anxiety disorder, social phobia, and panic disorder.J Anxiety Disord. 2009 Dec;23(8):1086-90. doi: 10.1016/j.janxdis.2009.07.011. Epub 2009 Jul 14. J Anxiety Disord. 2009. PMID: 19640675 Free PMC article.
-
[Efficacy and tolerability of escitalopram in anxiety disorders: a review].Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Encephale. 2008. PMID: 18922243 Review. French.
Cited by
-
Work-life balance mediating stress and quality of life in academics during COVID-19 in Malaysia.J Public Health Afr. 2024 Aug 31;15(1):562. doi: 10.4102/jphia.v15i1.562. eCollection 2024. J Public Health Afr. 2024. PMID: 39229342 Free PMC article.
-
Health-related quality of life in psychiatric outpatients: a cross-sectional study of associations with symptoms, diagnoses, and employment status.Qual Life Res. 2024 Aug 7. doi: 10.1007/s11136-024-03748-3. Online ahead of print. Qual Life Res. 2024. PMID: 39110377
-
Depression, anxiety, and poor well-being at discharge from psychiatric hospitals: prevalence and risk factors.Front Psychiatry. 2024 Jul 11;15:1408095. doi: 10.3389/fpsyt.2024.1408095. eCollection 2024. Front Psychiatry. 2024. PMID: 39056021 Free PMC article.
-
Cross-species analysis uncovers the mitochondrial stress response in the hippocampus as a shared mechanism in mouse early life stress and human depression.Neurobiol Stress. 2024 May 14;31:100643. doi: 10.1016/j.ynstr.2024.100643. eCollection 2024 Jul. Neurobiol Stress. 2024. PMID: 38800537 Free PMC article.
-
Social support in maintaining mental health and quality of life among community-dwelling older people with functional limitations in Malaysia: a population-based cross-sectional study.BMJ Open. 2024 May 15;14(5):e077046. doi: 10.1136/bmjopen-2023-077046. BMJ Open. 2024. PMID: 38754882 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical